Is FDA's revolving door open too wide?
Science
.
2018 Jul 6;361(6397):21.
doi: 10.1126/science.361.6397.21.
Author
Charles Piller
PMID:
29976809
DOI:
10.1126/science.361.6397.21
No abstract available
Publication types
News
MeSH terms
Advisory Committees / economics*
Conflict of Interest*
Drug Approval / economics*
United States
United States Food and Drug Administration